… RdRp of the COVID-19 RNA (17,18), here we report the preliminary results of the randomized,
controlled, phase II open-label clinical trial of the safety and efficacy of sofosbuvir among …

… clinical trial (ChiCTR2000029387) on patients with mild to moderate severity of COVID-19
divided into three groups (ribavirin (RBV) + Ia: LPV/RTV + IFN-a: ribavirin + LPV/r + IFN-a = 1:1…

… urgently in COVID-19 patients, such as interferon, ribavirin, hydroxychloroquine, lopinavir
and ritonavir, umifenovir, and so on. However, the specific effectiveness of these drugs for …

… preliminary efficacy for patients with COVID-19 in five … sofosbuvir and daclatasvir to standard
care improved clinical endpoints in hospitalized patients with moderate or severe COVID-19…

… efficacy against this global challenge. A systematic literature review was performed to screen
all of the related papers on COVID-19… safety and efficacy of remdesivir, ribavirin, favipiravir, …

… COVID-19. We found no direct evidence for treatment using ribavirin in a population of patients
with COVID-19, … no support for a reduction in mortality with ribavirin treatment.22 , 29 , 30 …

… of ribavirin efficacy from 2003 during SARS and the 2013 MERS outbreaks led to a summary
evaluation of its utility as controversial in the treatment of COVID-19 … of ribavirin efficacy in a …

… efficacy of Hydroxychloroquine with Ribavirin and standard treatment in patients with non-severe
COVID-19 … Symptomatic (severe or non-severe) Covid-19 disease 4. Willingness of …

… The present study presents a perfect model for COVID-19 … IDX-184, Sofosbuvir, and Ribavirin
against COVID-19 RdRp are … that IDX-184, Sofosbuvir, and Ribavirin can tightly bind to the …

… Other antiviral drugs have been suggested to be repurposed for the treatment of COVID-19,
such as interferon-ɑ, lopinavir/ritonavir, ribavirin, and remdesivir [5, 6]. Some clinical trials …